• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SARS COV 2 TESTING KITS; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SARS COV 2 TESTING KITS; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Device Problem Unexpected Therapeutic Results (1631)
Patient Problems Headache (1880); Pain (1994); Rash (2033); Burning Sensation (2146); Cognitive Changes (2551); Unspecified Eye / Vision Problem (4471); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 05/04/2022
Event Type  Injury  
Event Description
Weekly nasal testing from a variety of pcr/rapid testing for sars cov 2.Headaches, nasal burning, nasal rash, vibration/buzzing bees feeling behind the nose, sinus pressure, eye strain, brain fog, upper jaw pain.After several days of these things occurring, they would disappear only to reoccur immediately to 24 hours after another test was completed.County/school/and pharmacy provided kits.All brands.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SARS COV 2 TESTING KITS
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
MDR Report Key14565795
MDR Text Key293160392
Report NumberMW5109999
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 05/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/31/2022
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-